Allergan readies defense as it fights Valeant for votes
July 01, 2014 at 16:05 PM EDT
NEW YORK and LOS ANGELES (Reuters) - Allergan Inc may take on debt to buy back its own shares as part of a multi-faceted plan to thwart a $53 billion takeover bid by Valeant Pharmaceuticals International Inc and activist investor William Ackman.
